2014
DOI: 10.1016/j.cbpa.2014.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo

Abstract: The light-emitting chemical reaction catalyzed by the enzyme firefly luciferase is widely used for noninvasive imaging in live mice. However, photon emission from the luciferase is critically dependent on the chemical properties of its substrate, D-luciferin. In this review, we describe recent work to replace the natural luciferase substrate with synthetic analogs that extend the scope of bioluminescence imaging.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
95
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 123 publications
(96 citation statements)
references
References 61 publications
1
95
0
Order By: Relevance
“…1 Synthetic analogues containing amine or alkylamine donors are also luminogenic and can offer advantages for in vivo imaging. 2,3 However, to date most firefly luciferin substrates and “caged” sensors have been synthesized from 6-amino or 6-hydroxy benzothiazoles, placing inherent restrictions on the nature of the electron-donating 6′-functionality.…”
mentioning
confidence: 99%
“…1 Synthetic analogues containing amine or alkylamine donors are also luminogenic and can offer advantages for in vivo imaging. 2,3 However, to date most firefly luciferin substrates and “caged” sensors have been synthesized from 6-amino or 6-hydroxy benzothiazoles, placing inherent restrictions on the nature of the electron-donating 6′-functionality.…”
mentioning
confidence: 99%
“…The most red-shifted luciferin analogues to date[16] are based upon amino derivatives (Figure 1 b), for example cyclic aminoluciferin ( 3 a : λ max =599 nm; 3 b : λ max =607 nm),[17] seleno- d -aminoluciferin ( 4 : λ max =600 nm),[18] and a rationally designed 4-(dimethylamino)phenyl derivative conjugated to a thiazoline group ( 5 : λ max =675 nm). [19] In particular cyclic aminoluciferin derivative 3 a has been shown to give improved bioluminescence imaging compared to luciferin (LH 2 ; 1 ) at dilute concentrations where the intracellular concentration of the luciferin or analogue is limiting.…”
mentioning
confidence: 99%
“…Another way to enhance the performance of bioluminescent reporter systems is by modification of the luciferase substrates, which has yielded substrates showing increased brightness, a reduced sensitivity for autooxidation, different spectral properties, or enhanced bioavailability (Jiang, Du, & Li, 2016). Also, a range of "caged" substrates have been developed that can be used to report on the presence of specific enzymes such as β-galactosidase, glycosidase, and caspases (Adams & Miller, 2014;Jiang et al, 2016). Most BRET-sensors developed to date are based on Renilla luciferase or its improved variants such as the brighter RLuc8.…”
Section: Luciferases For Integration In Bret-sensorsmentioning
confidence: 99%